ABB’s ACS560 drives are playing a vital role in Bharat Biotech’s clean room infrastructure, where the company manufactures ‘Covaxin’, India’s first indigenous vaccine for Covid-19. Bharat Biotech supplied 20 million doses for the national vaccination roll-out in April and is targeting to produce 700 million doses per year.
ABB is a leading global technology company that energizes the transformation of society and industry to achieve a more productive, sustainable future.